{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:14:08Z","timestamp":1771460048832,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-02965-6","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T09:03:54Z","timestamp":1708419834000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correlation between gout and dry eye disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Tongtong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,20]]},"reference":[{"key":"2965_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatm ent patterns and risk factors. Nat Rev Rheumatol 16:380\u2013390. https:\/\/doi.org\/10.1038\/s41584-020-0441-1","journal-title":"Nat Rev Rheumatol"},{"key":"2965_CR2","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/S0140-6736(16)00346-9","volume":"388","author":"N Dalbeth","year":"2016","unstructured":"Dalbeth N, Merriman TR, Stamp LK (2016) Gout. Lancet 388:2039\u20132052. https:\/\/doi.org\/10.1016\/S0140-6736(16)00346-9","journal-title":"Lancet"},{"key":"2965_CR3","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","volume":"397","author":"N Dalbeth","year":"2021","unstructured":"Dalbeth N, Gosling AL, Gaffo A, Abhishek A (2021) Gout. Lancet 397:1843\u20131855. https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9","journal-title":"Lancet"},{"key":"2965_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3980\/j.issn.2222-3959.2013.03.09","volume":"6","author":"J Lin","year":"2013","unstructured":"Lin J, Zhao GQ, Che CY, Yang SS, Wang Q, Li CG (2013) Characteristics of ocular abnormalities in gout patients. Int J Ophthalmol 6:307\u2013311. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2013.03.09","journal-title":"Int J Ophthalmol"},{"key":"2965_CR5","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archopht.121.8.1195","volume":"121","author":"WR Morris","year":"2003","unstructured":"Morris WR, Fleming JC (2003) Gouty tophus at the lateral canthus. Arch Ophthalmol 121:1195\u20131197. https:\/\/doi.org\/10.1001\/archopht.121.8.1195","journal-title":"Arch Ophthalmol"},{"key":"2965_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ajo.2005.07.023","volume":"140","author":"WR Lo","year":"2005","unstructured":"Lo WR, Broocker G, Grossniklaus HE (2005) Histopathologic examination of conjunctival tophi in gouty arthritis. Am J Ophthalmol 140:1152\u20131154. https:\/\/doi.org\/10.1016\/j.ajo.2005.07.023","journal-title":"Am J Ophthalmol"},{"key":"2965_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ophtha.2005.11.012","volume":"113","author":"M Coassin","year":"2006","unstructured":"Coassin M, Piovanetti O, Stark WJ, Green WR (2006) Urate deposition in the iris and anterior chamber. Ophthalmology 113:462\u2013465. https:\/\/doi.org\/10.1016\/j.ophtha.2005.11.012","journal-title":"Ophthalmology"},{"key":"2965_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/ICO.0000000000001415","volume":"37","author":"A Yazdanyar","year":"2018","unstructured":"Yazdanyar A, Rizzuti AE, Mechel E, Denisova K, Lazzaro DR (2018) Gout keratitis: a case of peripheral ulcerative keratitis secondary to gout with a review of the literature. Cornea 37:379\u2013381. https:\/\/doi.org\/10.1097\/ICO.0000000000001415","journal-title":"Cornea"},{"key":"2965_CR9","first-page":"632","volume":"17","author":"AP Ferry","year":"1985","unstructured":"Ferry AP, Safir A, Melikian HE (1985) Ocular abnormalities in patients with gout. Ann Ophthalmol 17:632\u2013635","journal-title":"Ann Ophthalmol"},{"key":"2965_CR10","doi-asserted-by":"publisher","first-page":"e180188","DOI":"10.1371\/journal.pone.0180188","volume":"12","author":"C Luo","year":"2017","unstructured":"Luo C, Chen X, Jin H, Yao K (2017) The association between gout and cataract risk: a meta-analysis. PLoS ONE 12:e180188. https:\/\/doi.org\/10.1371\/journal.pone.0180188","journal-title":"PLoS ONE"},{"key":"2965_CR11","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocular Surface 15:276\u2013283. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.008","journal-title":"Ocular Surface"},{"key":"2965_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1046\/j.1442-9071.2003.00634.x","volume":"31","author":"EM Chia","year":"2003","unstructured":"Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ (2003) Prevalence and associations of dry eye syndrome in an older population: the blue mountains eye study. Clin Exp Ophthalmol 31:229\u2013232. https:\/\/doi.org\/10.1046\/j.1442-9071.2003.00634.x","journal-title":"Clin Exp Ophthalmol"},{"key":"2965_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","volume":"118","author":"SE Moss","year":"2000","unstructured":"Moss SE, Klein R, Klein BE (2000) Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol 118:1264\u20131268. https:\/\/doi.org\/10.1001\/archopht.118.9.1264","journal-title":"Arch Ophthalmol"},{"key":"2965_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1001\/archopht.122.3.369","volume":"122","author":"SE Moss","year":"2004","unstructured":"Moss SE, Klein R, Klein BE (2004) Incidence of dry eye in an older population. Arch Ophthalmol 122:369\u2013373. https:\/\/doi.org\/10.1001\/archopht.122.3.369","journal-title":"Arch Ophthalmol"},{"key":"2965_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1097\/OPX.0b013e318181a947","volume":"85","author":"SE Moss","year":"2008","unstructured":"Moss SE, Klein R, Klein BE (2008) Long-term incidence of dry eye in an older population. Optom Vis Sci 85:668\u2013674. https:\/\/doi.org\/10.1097\/OPX.0b013e318181a947","journal-title":"Optom Vis Sci"},{"key":"2965_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/meajo.MEAJO_281_16","volume":"24","author":"AA Alshamrani","year":"2017","unstructured":"Alshamrani AA, Almousa AS, Almulhim AA, Alafaleq AA, Alosaimi MB, Alqahtani AM, Almulhem AM, Alshamrani MA, Alhallafi AH, Alqahtani IZ, Alshehri AA (2017) Prevalence and risk factors of dry eye symptoms in a saudi arabian population. Mid East Afr J Ophthalmol 24:67\u201373. https:\/\/doi.org\/10.4103\/meajo.MEAJO_281_16","journal-title":"Mid East Afr J Ophthalmol"},{"key":"2965_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010062","author":"CY Lee","year":"2019","unstructured":"Lee CY, Chen HC, Sun CC, Lin HY, Lu KH, Huang JY, Yeh CB, Yang SF (2019) Gout as a risk factor for dry eye disease: a population-based cohort study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm8010062","journal-title":"J Clin Med"},{"key":"2965_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/ICL.0000000000000832","volume":"47","author":"S Belviranli","year":"2021","unstructured":"Belviranli S, Turk HB, Oltulu P, Turk N, Mirza E, K\u00fc\u00e7\u00fck A, Aydemir H, Oltulu R (2021) Tear function alterations and conjunctival impression cytology findings in patients with gout. Eye Cont Lens-Sci Clin Pract 47:647\u2013650. https:\/\/doi.org\/10.1097\/ICL.0000000000000832","journal-title":"Eye Cont Lens-Sci Clin Pract"},{"key":"2965_CR19","doi-asserted-by":"publisher","first-page":"e271267","DOI":"10.1371\/journal.pone.0271267","volume":"17","author":"L Qian","year":"2022","unstructured":"Qian L, Wei W (2022) Identified risk factors for dry eye syndrome: a systematic review and meta-analysis. PLoS ONE 17:e271267. https:\/\/doi.org\/10.1371\/journal.pone.0271267","journal-title":"PLoS ONE"},{"key":"2965_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11247378","author":"CY Lee","year":"2022","unstructured":"Lee CY, Lian IB, Jhan YN, Yang SF, Chang CK (2022) Lifestyle and symptom risk factors for dry eye disease in Asian gout population: a population-based case-control study. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11247378","journal-title":"J Clin Med"},{"key":"2965_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","volume":"79","author":"P Richette","year":"2020","unstructured":"Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Liote F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche A, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T (2020) 2018 updated European league against rheumatism evidence-based recommendations for the diagnosis of gout. Ann Rheum Dis 79:31\u201338. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215315","journal-title":"Ann Rheum Dis"},{"key":"2965_CR22","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.4049\/jimmunol.138.10.3213","volume":"138","author":"FS Di Giovine","year":"1987","unstructured":"Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138:3213\u20133218","journal-title":"J Immunol"},{"key":"2965_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","volume":"8","author":"G Ragab","year":"2017","unstructured":"Ragab G, Elshahaly M, Bardin T (2017) Gout: an old disease in new perspective: a review. J Adv Res 8:495\u2013511. https:\/\/doi.org\/10.1016\/j.jare.2017.04.008","journal-title":"J Adv Res"},{"key":"2965_CR24","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/JIR.S357159","volume":"15","author":"X Zha","year":"2022","unstructured":"Zha X, Yang B, Xia G, Wang S (2022) Combination of uric acid and pro-inflammatory cytokines in discriminating patients with gout from healthy controls. J Inflamm Res 15:1413\u20131420. https:\/\/doi.org\/10.2147\/JIR.S357159","journal-title":"J Inflamm Res"},{"key":"2965_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"key":"2965_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.abb.2019.01.031","volume":"670","author":"Z Szekanecz","year":"2019","unstructured":"Szekanecz Z, Szamosi S, Kov\u00e1cs GE, Kocsis E, Benk\u0151 S (2019) The NLRP3 inflammasome: interleukin 1 pathway as a therapeutic target in gout. Arch Biochem Biophys 670:82\u201393. https:\/\/doi.org\/10.1016\/j.abb.2019.01.031","journal-title":"Arch Biochem Biophys"},{"key":"2965_CR27","doi-asserted-by":"publisher","first-page":"4063562","DOI":"10.1155\/2020\/4063562","volume":"2020","author":"Z Wang","year":"2020","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T, Yue Y, Qian W, Li L (2020) NLRP3 inflammasome and inflammatory diseases. Oxid Med Cell Longev 2020:4063562. https:\/\/doi.org\/10.1155\/2020\/4063562","journal-title":"Oxid Med Cell Longev"},{"key":"2965_CR28","doi-asserted-by":"publisher","first-page":"e13108","DOI":"10.1097\/MD.0000000000013108","volume":"97","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Zhao M, Pu Z, Xu G, Li X (2018) Relationship between oxidative stress and inflammation in hyperuricemia: analysis based on asymptomatic young patients with primary hyperuricemia. Medicine 97:e13108","journal-title":"Medicine"},{"key":"2965_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.925876","author":"Y Lu","year":"2022","unstructured":"Lu Y, Wu Y, Zhou X, Inomata T, Gu L, Jin X, Hong J (2022) Editorial: advances in the pathophysiology, diagnosis, and treatment of dry eye disease. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.925876","journal-title":"Front Med"},{"key":"2965_CR30","first-page":"2283","volume":"42","author":"A Solomon","year":"2001","unstructured":"Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC (2001) Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci 42:2283\u20132292","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2965_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","volume":"26","author":"KC Yoon","year":"2007","unstructured":"Yoon KC, Jeong IY, Park YG, Yang SY (2007) Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. Cornea 26:431\u2013437. https:\/\/doi.org\/10.1097\/ICO.0b013e31803dcda2","journal-title":"Cornea"},{"key":"2965_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1076\/ceyr.19.3.201.5309","volume":"19","author":"SC Pflugfelder","year":"1999","unstructured":"Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D (1999) Altered cytokine balance in the tear fluid and conjunctiva of patients with Sj\u00f6gren\u2019s syndrome keratoconjunctivitis sicca. Curr Eye Res 19:201\u2013211. https:\/\/doi.org\/10.1076\/ceyr.19.3.201.5309","journal-title":"Curr Eye Res"},{"key":"2965_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.815075","author":"J Ling","year":"2022","unstructured":"Ling J, Chan BC, Tsang MS, Gao X, Leung PC, Lam CW, Hu J, Wong CK (2022) Current advances in mechanisms and treatment of dry eye disease: toward anti-inflammatory and immunomodulatory therapy and traditional Chinese medicine. Front Med. https:\/\/doi.org\/10.3389\/fmed.2021.815075","journal-title":"Front Med"},{"key":"2965_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","volume":"125","author":"Q Zheng","year":"2014","unstructured":"Zheng Q, Ren Y, Reinach PS, She Y, Xiao B, Hua S, Qu J, Chen W (2014) Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye. Exp Eye Res 125:1\u20138. https:\/\/doi.org\/10.1016\/j.exer.2014.05.001","journal-title":"Exp Eye Res"},{"key":"2965_CR35","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So A, De Smedt T, Revaz S, Tschopp J (2007) A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9:R28. https:\/\/doi.org\/10.1186\/ar2143","journal-title":"Arthritis Res Ther"},{"key":"2965_CR36","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1002\/art.41699","volume":"73","author":"KG Saag","year":"2021","unstructured":"Saag KG, Khanna PP, Keenan RT, Ohlman S, Osterling KL, Sparve E, \u00c5kerblad AC, Wik\u00e9n M, So A, Pillinger MH, Terkeltaub R (2021) A randomized, phase II study evaluating the efficacy and safety of anakinra in the treatment of gout flares. Arthritis Rheumatol 73:1533\u20131542. https:\/\/doi.org\/10.1002\/art.41699","journal-title":"Arthritis Rheumatol"},{"key":"2965_CR37","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","volume":"131","author":"F Amparo","year":"2013","unstructured":"Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Hamrah P, Jurkunas U, Schaumberg DA, Dana R (2013) Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. JAMA Ophthalmol 131:715\u2013723. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.195","journal-title":"JAMA Ophthalmol"},{"key":"2965_CR38","doi-asserted-by":"publisher","first-page":"e805","DOI":"10.1002\/iid3.805","volume":"11","author":"M Wu","year":"2023","unstructured":"Wu M, Hu X, Lu T, Liu C, Lu H (2023) Uric acid is independently associated with interleukin-1\u03b2 levels in tear fluid of hyperuricemia and gout patients. Immun Inflamm Dis 11:e805. https:\/\/doi.org\/10.1002\/iid3.805","journal-title":"Immun Inflamm Dis"},{"key":"2965_CR39","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.2147\/OPTH.S121256","volume":"10","author":"R Sambursky","year":"2016","unstructured":"Sambursky R (2016) Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. Clin Ophthalmol 10:2337\u20132343. https:\/\/doi.org\/10.2147\/OPTH.S121256","journal-title":"Clin Ophthalmol"},{"key":"2965_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/ICO.0000000000002979","volume":"42","author":"MS Magno","year":"2023","unstructured":"Magno MS, Utheim TP, Morthen MK, Snieder H, Jansonius NM, Hammond CJ, Vehof J (2023) The relationship between caffeine intake and dry eye disease. Cornea 42:186\u2013193. https:\/\/doi.org\/10.1097\/ICO.0000000000002979","journal-title":"Cornea"},{"key":"2965_CR41","doi-asserted-by":"publisher","first-page":"101409","DOI":"10.1016\/j.clae.2021.01.004","volume":"44","author":"M Wang","year":"2021","unstructured":"Wang M, Muntz A, Mamidi B, Wolffsohn JS, Craig JP (2021) Modifiable lifestyle risk factors for dry eye disease. Cont Lens Anterior Eye 44:101409. https:\/\/doi.org\/10.1016\/j.clae.2021.01.004","journal-title":"Cont Lens Anterior Eye"},{"key":"2965_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2021.108523","author":"A Shoari","year":"2021","unstructured":"Shoari A, Kanavi MR, Rasaee MJ (2021) Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study. Exp Eye Res. https:\/\/doi.org\/10.1016\/j.exer.2021.108523","journal-title":"Exp Eye Res"},{"key":"2965_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/bjo.85.2.147","volume":"85","author":"VA Smith","year":"2001","unstructured":"Smith VA, Rishmawi H, Hussein H, Easty DL (2001) Tear film MMP accumulation and corneal disease. Br J Ophthalmol 85:147\u2013153. https:\/\/doi.org\/10.1136\/bjo.85.2.147","journal-title":"Br J Ophthalmol"},{"key":"2965_CR44","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jtos.2020.10.003","volume":"19","author":"M Soifer","year":"2021","unstructured":"Soifer M, Mousa HM, Stinnett SS, Galor A, Perez VL (2021) Matrix metalloproteinase 9 positivity predicts long term decreased tear production. Ocular Surface 19:270\u2013274. https:\/\/doi.org\/10.1016\/j.jtos.2020.10.003","journal-title":"Ocular Surface"},{"key":"2965_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1001\/jamaophthalmol.2013.561","volume":"131","author":"R Sambursky","year":"2013","unstructured":"Sambursky R, Davitt WR, Latkany R, Tauber S, Starr C, Friedberg M, Dirks MS, McDonald M (2013) Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 131:24\u201328. https:\/\/doi.org\/10.1001\/jamaophthalmol.2013.561","journal-title":"JAMA Ophthalmol"},{"key":"2965_CR46","doi-asserted-by":"publisher","first-page":"109112","DOI":"10.1016\/j.intimp.2022.109112","volume":"111","author":"W Feng","year":"2022","unstructured":"Feng W, Zhong XQ, Zheng XX, Liu QP, Liu MY, Liu XB, Lin CS, Xu Q (2022) Study on the effect and mechanism of quercetin in treating gout arthritis. Int Immunopharmacol 111:109112. https:\/\/doi.org\/10.1016\/j.intimp.2022.109112","journal-title":"Int Immunopharmacol"},{"key":"2965_CR47","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.jsps.2022.04.013","volume":"30","author":"T Nutmakul","year":"2022","unstructured":"Nutmakul T (2022) A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharm J 30:918\u2013926. https:\/\/doi.org\/10.1016\/j.jsps.2022.04.013","journal-title":"Saudi Pharm J"},{"key":"2965_CR48","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/ICO.0000000000000543","volume":"34","author":"HN Oh","year":"2015","unstructured":"Oh HN, Kim CE, Lee JH, Yang JW (2015) Effects of quercetin in a mouse model of experimental dry eye. Cornea 34:1130\u20131136. https:\/\/doi.org\/10.1097\/ICO.0000000000000543","journal-title":"Cornea"},{"key":"2965_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111723","author":"M Sekine","year":"2021","unstructured":"Sekine M, Okamoto K, Ichida K (2021) Association of mutations identified in xanthinuria with the function and inhibition mechanism of xanthine oxidoreductase. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9111723","journal-title":"Biomedicines"},{"key":"2965_CR50","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2174\/1573406415666191004134346","volume":"16","author":"N Malik","year":"2020","unstructured":"Malik N, Khatkar A, Dhiman P (2020) Computational analysis and synthesis of syringic acid derivatives as xanthine oxidase inhibitors. Med Chem 16:643\u2013653. https:\/\/doi.org\/10.2174\/1573406415666191004134346","journal-title":"Med Chem"},{"key":"2965_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/aos.14892","volume":"100","author":"V Navel","year":"2022","unstructured":"Navel V, Sapin V, Henrioux F, Blanchon L, Labb\u00e9 A, Chiambaretta F, Baudouin C, Dutheil F (2022) Oxidative and antioxidative stress markers in dry eye disease: a systematic review and meta-analysis. Acta Ophthalmol 100:45\u201357. https:\/\/doi.org\/10.1111\/aos.14892","journal-title":"Acta Ophthalmol"},{"key":"2965_CR52","doi-asserted-by":"publisher","first-page":"997","DOI":"10.14670\/HH-22.997","volume":"22","author":"J Cejkov\u00e1","year":"2007","unstructured":"Cejkov\u00e1 J, Ardan T, Jirsov\u00e1 K, Jechov\u00e1 G, Malec J, Simonov\u00e1 Z, Cejka C, Filipec M, Dotrelov\u00e1 D, Brunov\u00e1 B (2007) The role of conjunctival epithelial cell xanthine oxidoreductase\/xanthine oxidase in oxidative reactions on the ocular surface of dry eye patients with Sj\u00f6gren\u2019s syndrome. Histol Histopathol 22:997\u20131003. https:\/\/doi.org\/10.14670\/HH-22.997","journal-title":"Histol Histopathol"},{"key":"2965_CR53","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.14670\/HH-23.1477","volume":"23","author":"J Cejkov\u00e1","year":"2008","unstructured":"Cejkov\u00e1 J, Ardan T, Simonov\u00e1 Z, Cejka C, Malec J, Dotrelov\u00e1 D, Brunov\u00e1 B (2008) Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sj\u00f6gren\u2019s syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol 23:1477\u20131483. https:\/\/doi.org\/10.14670\/HH-23.1477","journal-title":"Histol Histopathol"},{"key":"2965_CR54","doi-asserted-by":"publisher","first-page":"108058","DOI":"10.1016\/j.exer.2020.108058","volume":"196","author":"L Silvani","year":"2020","unstructured":"Silvani L, Bedei A, De Grazia G, Remiddi S (2020) Arabinogalactan and hyaluronic acid in ophthalmic solution: experimental effect on xanthine oxidoreductase complex as key player in ocular inflammation (in vitro study). Exp Eye Res 196:108058. https:\/\/doi.org\/10.1016\/j.exer.2020.108058","journal-title":"Exp Eye Res"},{"key":"2965_CR55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/OPX.0000000000000129","volume":"91","author":"KA Osei","year":"2014","unstructured":"Osei KA, Ovenseri-Ogbomo G, Kyei S, Ntodie M (2014) The effect of caffeine on tear secretion. Optom Vis Sci 91:171\u2013177. https:\/\/doi.org\/10.1097\/OPX.0000000000000129","journal-title":"Optom Vis Sci"},{"key":"2965_CR56","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.semarthrit.2016.01.003","volume":"45","author":"KY Park","year":"2016","unstructured":"Park KY, Kim HJ, Ahn HS, Kim SH, Park EJ, Yim SY, Jun JB (2016) Effects of coffee consumption on serum uric acid: systematic review and meta-analysis. Semin Arthritis Rheum 45:580\u2013586. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.01.003","journal-title":"Semin Arthritis Rheum"},{"key":"2965_CR57","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3945\/ajcn.2010.29565","volume":"92","author":"HK Choi","year":"2010","unstructured":"Choi HK, Curhan G (2010) Coffee consumption and risk of incident gout in women: the Nurses\u2019 health study. Am J Clin Nutr 92:922\u2013927. https:\/\/doi.org\/10.3945\/ajcn.2010.29565","journal-title":"Am J Clin Nutr"},{"key":"2965_CR58","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/art.22712","volume":"56","author":"HK Choi","year":"2007","unstructured":"Choi HK, Willett W, Curhan G (2007) Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum 56:2049\u20132055. https:\/\/doi.org\/10.1002\/art.22712","journal-title":"Arthritis Rheum"},{"key":"2965_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead019","author":"H Guo","year":"2023","unstructured":"Guo H, Wang S, Peng H, Wang M, Li L, Huang J, Wu T (2023) Dose-response relationships of tea and coffee consumption with gout: a prospective cohort study in the UK Biobank. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/kead019","journal-title":"Rheumatology"},{"key":"2965_CR60","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/art.22762","volume":"57","author":"HK Choi","year":"2007","unstructured":"Choi HK, Curhan G (2007) Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. Arthritis Rheum 57:816\u2013821. https:\/\/doi.org\/10.1002\/art.22762","journal-title":"Arthritis Rheum"},{"key":"2965_CR61","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/0024-3205(80)90492-0","volume":"27","author":"U Kela","year":"1980","unstructured":"Kela U, Vijayvargiya R, Trivedi CP (1980) Inhibitory effects of methylxanthines on the activity of xanthine oxidase. Life Sci 27:2109\u20132119. https:\/\/doi.org\/10.1016\/0024-3205(80)90492-0","journal-title":"Life Sci"}],"updated-by":[{"DOI":"10.1007\/s10792-024-03156-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000}}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-02965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-02965-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-02965-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:22:16Z","timestamp":1741879336000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-02965-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2965"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-02965-6","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,20]]},"assertion":[{"value":"19 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10792-024-03156-z","URL":"https:\/\/doi.org\/10.1007\/s10792-024-03156-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"102"}}